| P50 | author | Ralph A. Tripp | Q45349521 |
| | Robert A. Lamb | Q52258315 |
| | Stephen M Tompkins | Q59683451 |
| | Elizabeth W. Howerth | Q118780161 |
| P2093 | author name string | Yuan Lin | |
| | Jie Xu | |
| | Biao He | |
| | George P Leser | |
| | Joan E Durbin | |
| | Mary J Kennett | |
| | Russell K Durbin | |
| | Debra L Haas | |
| | Kari A Kramer | |
| P2860 | cites work | Kennel cough complex: confirmation and analysis of the outbreak in Japan | Q43695038 |
| | MULTIPLICATION OF A MYXOVIRUS (SV5) WITH MINIMAL CYTOPATHIC EFFECTS AND WITHOUT INTERFERENCE. | Q43994682 |
| | Viruses recovered from laboratory dogs with respiratory disease. | Q44656981 |
| | Recovery of infectious SV5 from cloned DNA and expression of a foreign gene | Q44671408 |
| | Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies | Q44763381 |
| | Epidemiologic studies of latent virus infections in captive monkeys and baboons. II. Serologic evidence of myxovirus infections with special reference to SV5. | Q44824069 |
| | Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species | Q44845116 |
| | T cell responses to the paramyxovirus simian virus 5: studies in multiple sclerosis and normal populations | Q45766519 |
| | Paramyxovirus SV5 and multiple sclerosis | Q58995564 |
| | Studies of canine respiratory viruses. I. Experimental infection of dogs with an SV5-like canine parainfluenza agent | Q68629074 |
| | New viral agents recovered from tissue cultures of monkey kidney cells. I. Origin and properties of cytopathogenic agents S.V.1, S.V.2, S.V.4, S.V.5, S.V.6, S.V.11, S.V.12 and S.V.15 | Q73954334 |
| | Recovery of negative-strand RNA viruses from plasmid DNAs: a positive approach revitalizes a negative field | Q74820893 |
| | Control of influenza virus infection by immunity to conserved viral features. | Q30343902 |
| | The paramyxovirus simian virus 5 V protein slows progression of the cell cycle | Q33604667 |
| | Reverse genetics of negative-strand RNA viruses: closing the circle | Q33701942 |
| | Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge | Q33783986 |
| | Effect of inserting paramyxovirus simian virus 5 gene junctions at the HN/L gene junction: analysis of accumulation of mRNAs transcribed from rescued viable viruses | Q33816333 |
| | Involvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5 | Q33820965 |
| | Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus | Q33835398 |
| | Recombinant Newcastle disease virus as a vaccine vector | Q33850246 |
| | Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates | Q34092801 |
| | A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned? | Q34155280 |
| | Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose | Q34418848 |
| | Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease | Q34624713 |
| | Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza | Q34650303 |
| | Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity | Q35855976 |
| | Negative-strand RNA viruses: genetic engineering and applications | Q37249720 |
| | Polypeptide Synthesis in Simian Virus 5-Infected Cells | Q37506235 |
| | Conserved cysteine-rich domain of paramyxovirus simian virus 5 V protein plays an important role in blocking apoptosis | Q37729964 |
| | Persistent SV5 virus infection in continuous cell cultures | Q39421248 |
| | The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation | Q39596942 |
| | Endothelial cells enhance human immunodeficiency virus type 1 replication in macrophages through a C/EBP-dependent mechanism | Q39604381 |
| | Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene | Q39732519 |
| | Parainfluenza-5 virus. Infection of man and animal | Q39895697 |
| | Isolation of parainfluenza virus SV5 from dogs with respiratory disease | Q39992139 |
| | Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody | Q40104834 |
| | A study of dogs with kennel cough | Q40148357 |
| | Function of small hydrophobic proteins of paramyxovirus | Q40324541 |
| | The role of simian virus 5 V protein on viral RNA synthesis | Q40410696 |
| | An investigation of the incidence, epidemiology and control of Simian virus 5. | Q40639683 |
| | Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling | Q40683477 |
| | Recombinant Sendai viruses expressing different levels of a foreign reporter gene. | Q40723470 |
| | Infectious rabies viruses from cloned cDNA. | Q40793123 |
| | Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation | Q40885459 |
| | Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5. | Q41109352 |
| | Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5). | Q42542975 |
| | Immunological relationships between parainfluenza virus type 4 and other paramyxoviruses studied by use of monoclonal antibodies | Q42543274 |
| | Comparison between parainfluenza virus type 2 and simian virus 5: monoclonal antibodies reveal major antigenic differences | Q42543343 |
| | A simian virus 5 (SV5) P/V mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function | Q43087027 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | influenza A virus | Q834390 |
| P304 | page(s) | 139-150 | |
| P577 | publication date | 2007-01-23 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge | |
| P478 | volume | 362 | |